BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 32402156)

  • 1. Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.
    Sise ME; Baggett MV; Shepard JO; Stevens JS; Rhee EP
    N Engl J Med; 2020 May; 382(22):2147-2156. PubMed ID: 32402156
    [No Abstract]   [Full Text] [Related]  

  • 2. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
    Thalha AMM; Lee YY; Besari A; Omar SFS
    J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychopharmacology of COVID-19.
    Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
    Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using "old" medications to fight new COVID-19: Re-purposing with a purpose.
    Wang Y; Foo R; Thum T
    J Mol Cell Cardiol; 2020 Sep; 146():41-42. PubMed ID: 32687852
    [No Abstract]   [Full Text] [Related]  

  • 5. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
    Wang D; Li Z; Liu Y
    J Infect Public Health; 2020 Oct; 13(10):1405-1414. PubMed ID: 32684351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of SARS-CoV-2: How far have we reached?
    Ahsan W; Javed S; Bratty MA; Alhazmi HA; Najmi A
    Drug Discov Ther; 2020 May; 14(2):67-72. PubMed ID: 32336723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncertainty about the Efficacy of Remdesivir on COVID-19.
    Yoo JH
    J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
    [No Abstract]   [Full Text] [Related]  

  • 8. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19: Rescue by transcriptional inhibition.
    Shilatifard A
    Sci Adv; 2020 Jul; 6(27):. PubMed ID: 32937442
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment options for COVID-19: The reality and challenges.
    Jean SS; Lee PI; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):436-443. PubMed ID: 32307245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatments for COVID-19: where are we now?
    Mendes A
    Br J Community Nurs; 2020 Aug; 25(8):412-413. PubMed ID: 32757900
    [No Abstract]   [Full Text] [Related]  

  • 12. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
    Li H; Liu Z; Ge J
    J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical manifestations and management of COVID-19-related liver injury.
    Su TH; Kao JH
    J Formos Med Assoc; 2020 Jun; 119(6):1016-1018. PubMed ID: 32345544
    [No Abstract]   [Full Text] [Related]  

  • 14. Kidney Transplantation and COVID-19.
    Merhi B; Gohh R
    R I Med J (2013); 2020 Sep; 103(8):34-37. PubMed ID: 32900010
    [No Abstract]   [Full Text] [Related]  

  • 15. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
    Ison MG; Wolfe C; Boucher HW
    JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438
    [No Abstract]   [Full Text] [Related]  

  • 16. Current treatment of COVID-19 in renal patients: hope or hype?
    Roberto P; Francesco L; Emanuela C; Giorgia G; Pasquale N; Sara D
    Intern Emerg Med; 2020 Nov; 15(8):1389-1398. PubMed ID: 32986137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audio Interview: Studying Potential Covid-19 Therapies.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(19):e72. PubMed ID: 32379957
    [No Abstract]   [Full Text] [Related]  

  • 18. Repurposing antimalarials and other drugs for COVID-19.
    Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
    Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019.
    Hase R; Kurata R; Ishida K; Kurita T; Muranaka E; Mito H
    Intern Med; 2020 Sep; 59(18):2327-2329. PubMed ID: 32727996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [COVID-19: a cardiological point-of-view].
    Weckbach LT; Kellnar A; Stremmel C; Stark K; Kääb S
    Dtsch Med Wochenschr; 2020 Jul; 145(15):1063-1067. PubMed ID: 32731280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.